Evaluation of Liver Stiffness Performance, by FibroScan®, to Detect Elevated Central Venous Pressure (CVP)

A trial with no phase registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 149 participants.

Also called NCT07222813

  • Study
  • In this atlas

Overview

Design
Interventional study; allocation not applicable; no masking; primary purpose diagnostic
Phase
Not applicable
Enrolled
  • 149 participants (planned count) (from the registry)
Sponsor
Registry
  • NCT NCT07222813
Started
(actual) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
United States, France, Germany, Poland (from the registry)
Registry status
  • Recruiting (from the registry)

Technical summary

Registry record NCT07222813. Allocation not applicable; no masking; primary purpose diagnostic. Start 2026-04-23 (actual); primary completion 2027-12-31 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Evaluation of Liver Stiffness Performance, by FibroScan®, to Detect Elevated Central Venous Pressure (CVP)
Condition
Heart Failure
Condition
Heart Failure - NYHA II - IV
Intervention (Device)
FibroScan
Intervention (Procedure)
Right-sided Heart Catheterization
Intervention (Procedure)
Transthoracic echocardiography
Intervention (Biological)
Blood Sample Analysis
Lead sponsor
Echosens (class: industry)
Collaborator
Syneos Health (class: other)

Record details

Record id
cardio:ct-nct07222813
Content hash
c434ffec67fdc65db88da77625a7707820f60614420cf8e1bf9e751489c2eb45